# Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin

> **NCT00362934** · PHASE3 · COMPLETED · sponsor: **Solvay Pharmaceuticals** · enrollment: 516 (actual)

## Conditions studied

- Hyperlipidemia

## Interventions

- **DRUG:** fenofibrate / simvastatin
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00362934
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 516 (ACTUAL)
- **Last updated:** 2009-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00362934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00362934, "Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00362934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*